FOCAL 2021 Annual Meeting

7:20 am – 7:30 am
Welcome - Arvin K. George, MD

7:30 am – 7:50 am
Prostate MRI for the Urologist
Baris Turkbey, MD

7:50 am – 8:05 am
The Manogram: Role of MRI in Prostate Cancer Screening
Peter A. Pinto, MD

8:05 am – 8:20 am
Discussion

8:20 am – 8:35 am
Rationale for Focal Therapy
Jim Wysock, MD

8:35 am – 8:50 am
Patient Selection - Uses and Misuses of Focal Therapy
Laurence Klotz, MD

8:50 am – 9:00 am
PET Imaging for Selection of Focal Therapy Candidates
TBD, MD

9:00 am – 9:15 am
Discussion

9:15 am – 9:45 am
BREAK

9:45 am – 10:00 am
Focal Therapy vs. Active Surveillance for Low Volume GG2 Disease
Stacy Loeb, MD

10:00 am – 10:10 am
Prostate Cancer Biomarkers and Focal Therapy
Simpa S. Salami, MD

10:10 am – 10:25 am
Point Counterpoint:

10:10 am
Focal Therapy Can Be Done for MRI Invisible Disease:  Arvin George, MD

10:17 am
Focal Therapy Should Not Be Done for MRI Invisible Disease: Simpa S.Salami, MD

10:25 am – 10:45 am
Introduction of Disruptive Technologies: The Lessons from the Minimally Invasive Surgery
Inderbir S. Gill, MD

10:45 am – 11:00 am
Discussion

11:00 am – 11:30 am
KEYNOTE LECTURE: The Unlikely Candidates: Focal Therapy for Low and High-Risk Prostate Cancer Patients
Caroline Moore, MD

11:30 am – 11:45 am
Discussion

12:45 pm – 12:55 pm
Modalities, Maps and Margins: Optimizing Oncologic Efficacy
Rafael Sanchez Salas, MD

12:55 pm – 1:05 pm
Patient Safety: Operative Techniques to Minimize Morbidity
Lance Mynderse, MD

1:05 pm – 1:15 pm
Discussion

1:15 pm – 2:15 pm
Balloon Debate: Optimal Management of Radio-Recurrent Unifocal Disease
Moderator: Abhinav Sidana, MD, MPH

-Active Surveillance – Stacy Loeb, MD

-Androgen Deprivation Therapy – Amir Lebatschi, MD

-Cryo – Thomas Polascik, MD, FACS

-HIFU – Caroline Moore, MD

 -Radiation – Amar Kishan, MD

-Salvage Radical Prostatectomy – Peter Pinto, MD

3:00 pm – 3:30 pm
In-Office Transperineal Interventions
Arvin K. George, MD

3:30 pm – 4:30 pm
Live Hands-on Lab*

3:00 pm – 3:10 pm
Introduction – Workup/Guidelines
Amin S. Herati, MD

3:10 pm – 3:20 pm
Rezum – Christopher Dixon, MD

3:20 pm – 3:30 pm
Urolift - Amin S. Herati, MD

3:30 pm – 3:40 pm
Enucleation – John Wei, MD

3:40 pm – 3:50 pm
iTind - Jonathan N. Warner, MD

3:50 pm – 4:00 pm
Aquablation – Brian Helfand, MD, PhD

4:00 pm – 4:10 pm
Summary - Amin S. Herati, MD

4:10 pm – 4:20 pm
Discussion

4:20 pm – 4:30 pm
BREAK

4:30 pm – 6:00 pm
Live Hands-on Lab*

4:30 pm – 6:00 pm
Live Hands-on Lab*

7:00 am – 7:30 am
In-Office Transperineal Interventions
Arvin K. George, MD

7:30 am – 8:30 am
Live Hands-on Lab*

7:00 am – 7:10 am
Introduction – Workup/GuidelinesI
Amin S. Herati, MD

7:10 am – 7:20 am
Rezum – Christopher Dixon, MD

7:20 am – 7:30 am
Urolift - Amin S. Herati, MD

7:30 am – 7:40 am
Enucleation – John Wei, MD

7:40 am – 7:50 am
iTind - Jonathan N. Warner, MD

7:50 am – 8:00 am
Aquablation – Brian Helfand, MD, PhD

8:00 am – 8:10 am
Summary - Amin S. Herati, MD

8:10 am – 8:20 am
Discussion

8:20 am – 8:30 am
BREAK

8:30 am – 10:00 am
Live Hands-on Lab*

8:30 am – 10:00 am
Live Hands-on Lab*

10:30 am – 10:40 am
Role of PSA and Biomarkers in Assessing Focal Therapy Success
TBD        

10:40 am – 10:50 am
MRI Imaging After Focal Therapy: What and When?
Baris Turkbey, MD

10:50 am – 11:00 am
Protocol Biopsy for Surveillance After Focal Therapy
Kia Michel, MD

11:00 am – 11:15 am
Discussion

11:15 am – 11:30 am
Complications of Focal Therapy - Risk Factors, Timepoints, Management
Rafael Sanchez Salas, MD

11:30 am – 11:50 am
Mechanisms and Management of Recurrence
TBD

11:50 am – 12:00 pm
Discussion

12:00 pm – 1:00 pm
LUNCH (Industry Sponsored)

1:00 pm – 1:15 pm
Abstract Presentations
Andre Abreu, MD

1:15 pm – 2:00 pm
Case Discussions
Andre Abreu, MD, Jonathan Coleman, MD, Rafael Sanchez Salas, MD

2:00 pm – 2:15 pm
Outcomes of Existing Focal Therapy Energy Modalities
Amir Lebastchi, MD

2:15 pm – 2:25 pm
Focal Therapy Society Update
Thomas Polascik, MD, FACS

2:25 pm – 2:40 pm
Discussion

2:40 pm – 2:55 pm
Block by Block: Building a Focal Therapy Program
Art Rastinehad, DO

2:55 pm – 3:05 pm
Billing and Reimbursement*
Karen Cornett, Hugo Embert

3:05 pm – 3:20 pm
Discussion

3:20 pm – 3:30 pm
Prostate Ablation and Antitumor Immune Response
Abhinav Sidana, MD, MPH

3:30 pm – 3:40 pm
Triopsy: Precision Sampling and Localization of Prostate Cancer
E. David Crawford, MD

3:40 pm – 3:50 pm
New Modality #1*

3:50 pm – 4:00 pm
New Modality #2*

4:00 pm – 4:05 pm
Conclusion